The 10th Annual Functional High Throughput Technologies Australia (FHTTA) Meeting will be held on October 30-31st 2019 at the John Curtin School of Medical Research at the ANU in Canberra (https://fhtta.com/). This meeting is organized by A. Prof. Kaylene Simpson (Peter McCallum Cancer Centre), Dr. Amee George (John Curtin School of Medical Research, ANU), Dr, John Lock (School of Medical Sciences, UNSW) and Ms. Moana Simpson (Griffith Institute of Drug Discovery (Griffith University) and will cover the topic of High-Content phenotypic screenings, organ-on-a-chip technology, 3D-high-throughput drug screenings, genome-wide CRISPR perturbation screenings and precision oncology. Opportunities f
This symposium will showcase recent developments in 3D tissue culture, stem cell technology, automation, micro and nano fabrication. This forum will also address key challenges for developing these technologies to replicate important aspects of disease progression and pathogenesis. This meeting will take place in Geelong Australia with the final day at Australia’s national biocontainment facility. Further information can be found on the website: here.
“Organoids Are Us 2019” was a one-day symposium held at the Walter and Eliza Hall Institute (WEHI) featuring research involving organoids. Organoid technologies have been a game changing advance to science and medicine that are the direct result of the discovery of Lgr5 as a cell-surface marker of adult stem cells in 2007 by the Clevers laboratory in the Netherlands (Barker et al., Nature 449:1003 with >2600 citations). The Clevers lab then went on to demonstrate that these tissue-restricted adult stem cells can be coerced into forming mini-replicas of tissues, termed “organoids”, meaning “organ-like” (Sato et al., Nature 2009 459:262 with >2000 citations). Organoids can be readily manipulat
